https://www.selleckchem.com/pr....oducts/Aloxistatin.h
97±0.14mm. The duration of the TAVR procedure to discharge was not significantly different (9.7±2.0 days vs. 13.2±1.0 days; p=0.239). We did not experience in-hospital death in both groups, and no significant differences were observed in the incidence of major adverse cardiac and cerebrovascular events between the two groups. The post-discharge survival rate was not significantly different between the groups (at 2-year; MITS group vs. TF group=91.0% vs. 89.0%; p=0.725). The MITS-TAVR using 18 Fr Dryseal Flex sheath was safe and effe
Like
Comment
Share
